Norwich Research Park gets £12.5m investment
October 3, 2014Medical Communications, Research and Development, Sales and Marketing BBSRC, The Genome Analysis Centre (TGAC), The Sainsbury Laboratory, jic, norwich research park, the Institute of Food Research and the University of East Anglia (UEA). Plant Bioscience Limited, the Norfolk and Norwich University Hospital and The SAW Trust
The government has injected £12.5 million into the research institutions of Norwich Research Park to fund its doctoral training programme. …
Roche falls foul of NICE rules, again
October 3, 2014Medical Communications, Sales and Marketing CLL, Gazyvaro, NICE, Roche, blood cancer, oncology
Uncertainties in the data and high cost have seen NICE make an initial rejection of Roche’s new blood cancer drug …
Mixed response to EMA data transparency plans
October 3, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency
The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …
Kymab makes appointments and executive promotions
October 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lisha Patel, Timothy Wells, jenny yip, kymab
Following a $40 million investment from The Wellcome Trust and the Bill & Melinda Gates Foundation, biopharma UK firm Kymab …
M3 Europe appoints new business director
October 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Paul Townley-Jones, m3 europe
Healthcare tech services firm M3 Europe has appointed a business director for its European division in Paul Townley-Jones.
Bexsero and Sirturo clear winners at UK Prix Galien Awards
October 2, 2014Medical Communications, Research and Development, Sales and Marketing 2014, Bexsero, Janssen, Novartis, awards, prix galien, sirturo
The first TB medication to be approved in four decades and the first ever vaccine to treat invasive meningococcal disease …
Conservative government would ‘protect’ NHS
October 2, 2014Medical Communications, Sales and Marketing Conservatives, Labour, Miliband, NHS, burnham, david cameron, lib dems
A majority Conservative government would protect the English NHS budget in real terms from 2015 to 2020, the British prime …
Biogen Idec hires senior vice president
October 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, gene, olivier danos
US-based biotech firm Biogen Idec has hired Dr Olivier Danos to be the senior vice president of its gene therapy …
Microsoft unveils new operating system
October 1, 2014Medical Communications, Sales and Marketing EFPIA, Microsoft, Operating Systems, Solidsoft, start, windows 10
Microsoft has announced its next operating system is now due for release next year and is to host a variety …
Charities must be clear about pharma funding
October 1, 2014Medical Communications, Sales and Marketing ABPI, NICE, Sativex, charity, funding, mind, pharma
There is growing need for transparency around patient groups and health charities as they are widely perceived to be independent …
J&J bets $1.75 billion on virology
October 1, 2014Research and Development, Sales and Marketing AL-8176, Alios BioPharma, J&J, JJ, Janssen, sovaldi, viral
Johnson & Johnson has signed a deal to acquire Alios BioPharma, a privately-held company focussed on developing therapies for viral …
Chemia appoints network manager
October 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Duncanson-Hunter, Pan, Red Door, chemia
Creston Health-owned network of agencies offering Chemia has hired a manager to run its operations. Ellie Duncanson-Hunter has been appointed …
SHL to introduce product Case Studies at the 2014 PDA Conference
October 1, 2014Sales and Marketing auto injectors, case studies, pen injectors, shl group
Taking an advanced injection device from concept to reality requires careful planning, key design and manufacturing competencies and a thorough …
Boehringer spends €100 million on inhaler
September 30, 2014Manufacturing and Production, Sales and Marketing Boehringer, Germany, Spiriva, Striverdi, inhaler, olodaterol, respimat
Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …
UK to ‘guarantee’ seven-day access to GPs
September 30, 2014Medical Communications, Research and Development, Sales and Marketing BMA, Cameron, GPs, NHS, UK, doctors
Under a UK Conservative government everyone would have access to GP care seven days a week as well as a …
Gilead to shift plant and expand US manufacturing
September 30, 2014Manufacturing and Production AmBisome, Cayston, Gilead, San Dimas, Viread, california, manufacturing
Gilead Sciences will move its US manufacturing plant about 15 minutes down the road to a 23-acre site in the …
New director for NHS England
September 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS England, richard jeavons
Richard Jeavons will be joining NHS England as its new director of specialised commissioning. Jeavons will report to Dame Barbara …
Lucideon expands pharma testing facilities
September 29, 2014Manufacturing and Production, Sales and Marketing bioburden, ceram, freeman, labs, lucideon, manufacturing, stoke
Materials development firm Lucideon has opened new pharmaceutical quality control testing laboratories at its UK headquarters in Stoke-on-Trent. The £1.5 …
BMS therapeutic cancer vaccine given swift FDA appraisal
September 29, 2014Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, Vaccine, bristol myers-squibb, keytruda, melanoma, opdivo
Bristol-Myers Squibb has been granted a speedy review for its new cancer immunotherapy drug Opdivo by the FDA for patients …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
